资讯

pharmaphorum4 年
AZ's COPD triple therapy approved in the US
AstraZeneca’s triple therapy for chronic obstructive pulmonary disease (COPD), Breztri Aerosphere (budesonide+glycopyrrolate ... and the patent on the Diskus inhaler expired in 2015.
University of Manchester3 年
Trial of new triple inhaler shows 20% reduction in COPD flare-ups
Flare-ups in chronic obstructive pulmonary disease, the UK’s fourth leading cause of death, can be reduced by 20% by a combined triple inhaler, according to the results of a ... “This is the first ...
pharmaphorum7 年
AZ boosted by COPD triple inhaler results
AstraZeneca may mount a challenge to GlaxoSmithKline’s three-in-one inhaler for chronic obstructive pulmonary disease (COPD ... Chiesi also has a rival triple therapy approved in Europe.
Medpage Today on MSN3 个月
Environmentally Friendlier COPD Inhaler May Also Be More Effective
Metered-dose inhaler budesonide-glycopyrrolate-formoterol ... The other single-inhaler on the market for COPD triple therapy, ...